Germany’s Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.
Source:: Reuters – Business News
Newswire
- [ July 22, 2026 ] Liquidia (NASDAQ: LQDA) Stock Analysis: Can Liquidia Become the Next Great Specialty Pharma? Arena Signals
- [ July 22, 2026 ] Intellia Therapeutics (NASDAQ: NTLA) Stock Analysis: Can CRISPR Deliver Its First Blockbuster? Arena Signals
- [ July 20, 2026 ] Fortress Biotech (NASDAQ: FBIO) Stock Analysis: Building a Biotech Empire—One Deal at a Time Arena Signals
- [ July 17, 2026 ] Fastly (NASDAQ: FSLY) Stock Analysis: Edge Platform Reaches an Inflection Point Arena Signals
- [ July 17, 2026 ] Innoviz Technologies (NASDAQ: INVZ) Stock Analysis: Building the Perception Layer for the Physical AI Revolution Arena Signals
- [ July 17, 2026 ] Neuronetics (NASDAQ: STIM) Stock Analysis: Building an Integrated Mental Health Treatment Platform Arena Signals
- [ July 16, 2026 ] AST SpaceMobile (NASDAQ: ASTS) Stock Analysis: Building World’s First Space-Based Broadband Provider Arena Signals
- [ July 14, 2026 ] GameStop (NYSE: GME) Stock Analysis: Profitable Turnaround — Is Ryan Cohen This Generation’s Warren Buffett? Arena Signals
- [ July 14, 2026 ] Quantum (NASDAQ: QMCO) Stock Analysis: Rebuilding the Data Infrastructure Company for the AI Era Arena Signals
- [ July 14, 2026 ] Expensify (NASDAQ: EXFY) Stock Analysis: Building the AI-Native Financial Superapp for Business Spending Arena Signals
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.